-
Kids and obesity: much more than a fizzy drink tax is needed!
20 February 2013
ANH-Intl looks at some of the challenges and solutions facing the childhood obesity epidemic
-
News Alerts: Week 07, 2019
13 February 2019
Pharma hijack of CBD market?; UK diets getting worse; All change for NZ supplement regs; The safety of supplements; Does breakfast help or hinder you?
-
Food4Health Campaign
Confused by what government’s are saying we should be eating? You’re not alone! Government guidelines are based on outdated or flawed science. Worse, they’re contributing to making people sick, fat and tired. Find out more about what healthy eating is really all about.
-
Vitamin supplements – rebutting fake prejudice
08 February 2017
Why supplements do so much more than give you expensive pee. We compare actual and optimal intakes and reveal the truth!
-
Sunday Times late-winter attack on high dose vitamin D
26 February 2020
Identifying the hallmarks of manufactured anti-vitamin hype
News / Health Choice / Health / Activism / Research
-
News Alerts: Week 37, 2016
14 September 2016
Thailand to vaccinate 400,000 against HPV, New drug may increase social interaction in autism patients, A fluoride free Bedford, Latest Government data shows a reduction in sugar intake from soft drinks, FluMist vaccine only 3% effective in preventing Flu, Magazine sentenced for defamation in Séralini court case
-
Organic shoppers back ANH lawsuit (1)
10 October 2007
Leading organic wholefood and natural remedies retailer Fresh & Wild is donating 5% of one day's (15 July) turnover to the ANH campaign.
-
Instilling healthy food habits from childhood
28 October 2015
Breaking the cycle of deadly diets with the ANH Food4Kids guidelines
-
Worried that your herbs might be messing with your drugs?
27 September 2018
How seriously should we take the latest study to warn people about natural health product safety?
News / Health Choice / Campaigns / Research
-
Crunch time for US supplements in the EU?
29 November 2017
Skyrocketing rate of EU ‘safety’ alerts provides key tool to protect pharma interest